Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
MOSAR
1 other identifier
observational
1,200
1 country
1
Brief Summary
Data on occurrence of antimicrobial resistant bacteria acquisition in rehabilitation centers will be collected. After removal of patient identifiers, information regarding the patients population will be entered into electronic sheet. The phase will last twelve months in each center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 6, 2008
CompletedFirst Posted
Study publicly available on registry
October 16, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedOctober 16, 2008
October 1, 2008
1 year
October 6, 2008
October 15, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A rehabilitation center's department in which the hospitalized patients are older then 18 years old.
1 YEAR
Study Arms (1)
rehabilitation center's hospitalized patients
Eligibility Criteria
A rehabilitation center's department in which the hospitalized patients are older then 18 years old.
You may qualify if:
- Hospitalized patients are older then 18 years old
You may not qualify if:
- Age 18 years or less
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tasmc
Tel Aviv, 64239, Israel
Related Publications (9)
Vovko P, Retelj M, Cretnik TZ, Jutersek B, Harlander T, Kolman J, Gubina M. Risk factors for colonization with methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infect Control Hosp Epidemiol. 2005 Feb;26(2):191-5. doi: 10.1086/502525.
PMID: 15756891BACKGROUNDLucet JC, Grenet K, Armand-Lefevre L, Harnal M, Bouvet E, Regnier B, Andremont A. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol. 2005 Feb;26(2):121-6. doi: 10.1086/502514.
PMID: 15756880BACKGROUNDBen-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis. 2006 Apr 1;42(7):925-34. doi: 10.1086/500936. Epub 2006 Feb 27.
PMID: 16511754BACKGROUNDStelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003 Oct 8;290(14):1899-905. doi: 10.1001/jama.290.14.1899.
PMID: 14532319BACKGROUNDCampbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000 Sep 16;321(7262):694-6. doi: 10.1136/bmj.321.7262.694. No abstract available.
PMID: 10987780BACKGROUNDPope C, van Royen P, Baker R. Qualitative methods in research on healthcare quality. Qual Saf Health Care. 2002 Jun;11(2):148-52. doi: 10.1136/qhc.11.2.148.
PMID: 12448807BACKGROUNDBartholomew LK, Parcel GS, Kok G. Intervention mapping: a process for developing theory- and evidence-based health education programs. Health Educ Behav. 1998 Oct;25(5):545-63. doi: 10.1177/109019819802500502.
PMID: 9768376BACKGROUNDvan Bokhoven MA, Kok G, van der Weijden T. Designing a quality improvement intervention: a systematic approach. Qual Saf Health Care. 2003 Jun;12(3):215-20. doi: 10.1136/qhc.12.3.215.
PMID: 12792013BACKGROUNDSmith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3709-14. doi: 10.1073/pnas.0400456101. Epub 2004 Feb 25.
PMID: 14985511BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Yehuda carmeli, MD MPH
TASMC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
October 6, 2008
First Posted
October 16, 2008
Study Start
October 1, 2008
Primary Completion
October 1, 2009
Study Completion
January 1, 2014
Last Updated
October 16, 2008
Record last verified: 2008-10